XML 88 R64.htm IDEA: XBRL DOCUMENT v3.22.1
FINANCIAL INSTRUMENTS (Tables)
12 Months Ended
Dec. 31, 2021
Financial Instruments  
Schedule of financial assets
            
   December 31, 
   2020   2021   2021 
   CNY   CNY   US$ 
   (As adjusted)         
             
Debt instruments at amortized cost:               
Accounts and bills receivable - current   29,771    41,526    6,533 
Accounts and bills receivable - non-current   31,676    9,501    1,495 
Financial assets included in other receivables   1,118    85,224    13,408 
Due from related companies   123,893         
Financial assets at fair value through profit or loss               
Listed equity investments (i)   138,674         
Structured deposit (ii)   5,000         
                
Total   330,132    136,251    21,436 
                
Total current   298,456    126,750    19,941 
Total non-current   31,676    9,501    1,495 
Schedule of financial liabilities
            
   December 31,   December 31,   December 31, 
   2020   2021   2021 
   CNY   CNY   US$ 
   (As adjusted)         
             
Derivatives not designated as hedging instruments:               
Derivative financial liabilities (i)       1,710    269 
Financial liabilities at amortized cost:               
Trade payables   28,621    21,118    3,321 
Financial liabilities in other payables and accruals   4,605    5,903    929 
Dividends payable       5,048    794 
Lease liabilities   3,550    2,189    345 
Due to related companies   79,459    5,710    898 
Due to the Shareholder   7,149    14,050    2,211 
Interest-bearing loans and borrowings   80,000    77,000    12,115 
                
Total   203,384    132,728    20,882 
                
Total current   124,216    57,520    9,048 
Total non-current   79,168    75,208    11,834 

 

(i)On January 20, 2021, the Company entered into a securities purchase agreement with certain institutional investors, pursuant to which the Company issued and sold on January 22, 2021, (i) in a registered direct offering, an aggregate of 3,960,000 of its common shares at a price of US$1.85 per share, and (ii) in a concurrent private placement, warrants initially exercisable for the purchase of an aggregate of 1,584,000 of its common shares with an initial exercise price of US$2.35 per share. Refer to Note 25 for further details.
Fair value of investments
                         
   December 31, 
   2020   2021   2021 
   CNY   CNY   US$ 
   (As adjusted)         
  

Carrying

amount

  

Fair

value

  

Carrying

amount

  

Fair

value

  

Carrying

amount

  

Fair

value

 
                         
Financial liabilities                              
Interest-bearing loans and borrowings   80,000    82,184    77,000    79,003    12,115    12,430 
                               
Total   80,000    82,184    77,000    79,003    12,115    12,430 

 

The following table provides the fair value measurement hierarchy of the Group’s financial assets and financial liabilities as of December 31, 2020 and 2021:

 

As of December 31, 2020 (As adjusted)  Fair value measurement using 
  

Quoted prices in active markets

(Level 1)

  

Significant observable inputs

(Level 2)

  

Significant

unobservable inputs

(Level 3)

   Total 
   CNY   CNY   CNY   CNY 
                 
Recurring fair value measurement:                    
                     
Financial assets                    
Structured deposit       5,000        5,000 
Financial assets at fair value through profit or loss   138,674            138,674 
Total financial assets   138,674    5,000        143,674 

 

As of December 31, 2021  Fair value measurement using 
  

Quoted prices in active markets

(Level 1)

  

Significant observable inputs

(Level 2)

  

Significant

unobservable inputs

(Level 3)

   Total 
   CNY   CNY   CNY   CNY 
                 
Recurring fair value measurement:                    
                     
Financial liabilities                    
Derivative financial liabilities       1,710        1,710 

 

As of December 31, 2021  Fair value measurement using 
  

Quoted prices in active markets

(Level 1)

  

Significant observable inputs

(Level 2)

  

Significant

unobservable inputs

(Level 3)

   Total 
   US$   US$   US$   US$ 
                 
Recurring fair value measurement:                    
                     
Financial liabilities                    
Derivative financial liabilities       269        269